Visser W, Wallenburg H C
Department of Obstetrics and Gynecology, Erasmus University School of Medicine and Health Sciences, Rotterdam, The Netherlands.
Hypertension. 1991 Jun;17(6 Pt 2):1072-7. doi: 10.1161/01.hyp.17.6.1072.
Reported central hemodynamics obtained with a Swan-Ganz pulmonary artery thermodilution catheter in preeclamptic patients show marked disparity, which has been interpreted to indicate a variable hemodynamic expression of the disease. However, the variability also may be due, at least in part, to the pharmacological treatment that most of the women studied received during Swan-Ganz measurements. To evaluate the effects of treatment on hemodynamics, we compared the results of Swan-Ganz measurements in 87 preeclamptic women who had received no treatment at all with those obtained in 47 preeclamptic women who had received various drugs and intravenous fluids. Control values were obtained in 10 normotensive pregnant volunteers. Measurements were performed between 25 and 34 weeks of gestation. The median (range) cardiac index in the untreated patients of 3.3 (2.0-5.3) l.min-1.m-2 was significantly lower than that in the treated patients of 4.3 (2.4-7.6) l.min-1.m-2 and in the normotensive pregnant women of 4.2 (3.5-4.6) l.min-1.m-2. The systemic vascular resistance index in the untreated group of 3,003 (1,771-5,225) dyne.sec.cm-5.m2 was significantly higher than that of 2,212 (1,057-3,688) in the treated and of 1,560 (1,430-2,019) dyne.sec.cm-5.m2 in the normotensive control group. The median (range) pulmonary capillary wedge pressure in the untreated group was 7 (-1-20) mm Hg and did not differ from that of 7 (0-25) mm Hg in the treated group. Variability of all hemodynamic variables was much lower in untreated than in treated patients.(ABSTRACT TRUNCATED AT 250 WORDS)
据报道,使用Swan-Ganz肺动脉热稀释导管测得的子痫前期患者的中心血流动力学表现出明显差异,这被解释为表明该疾病存在血流动力学表现的变异性。然而,这种变异性至少部分可能是由于大多数接受研究的女性在进行Swan-Ganz测量期间接受了药物治疗。为了评估治疗对血流动力学的影响,我们比较了87名未接受任何治疗的子痫前期女性与47名接受了各种药物和静脉输液的子痫前期女性的Swan-Ganz测量结果。在10名血压正常的怀孕志愿者中获取了对照值。测量在妊娠25至34周之间进行。未治疗患者的心脏指数中位数(范围)为3.3(2.0 - 5.3)升·分钟⁻¹·米⁻²,显著低于接受治疗患者的4.3(2.4 - 7.6)升·分钟⁻¹·米⁻²以及血压正常的孕妇的4.2(3.5 - 4.6)升·分钟⁻¹·米⁻²。未治疗组的全身血管阻力指数为3003(1771 - 5225)达因·秒·厘米⁻⁵·米²,显著高于治疗组的2212(1057 - 3688)以及血压正常对照组的1560(1430 - 2019)达因·秒·厘米⁻⁵·米²。未治疗组的肺毛细血管楔压中位数(范围)为7(-1 - 20)毫米汞柱,与治疗组的7(0 - 25)毫米汞柱无差异。未治疗患者所有血流动力学变量的变异性远低于接受治疗的患者。(摘要截取自250字)